Hongxin Li

Dr. Hongxin Li


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2023 in Frontiers in Medicine
Verified
Journal Article
Open access
HLHongxin Li
Hongxin Li
CZCui Zhang
Cui Zhang
KZKai Zhang
Kai Zhang
YLYi-Zhe Liu
Yi-Zhe Liu
XPXiao-Xiao Peng
Xiao-Xiao Peng
QZQiang Zong
Qiang Zong
Background: The relationship between inflammatory bowel disease (IBD) and the risk of Parkinson’s Disease (PD) has been investigated in several epidemiological studies. However, the results of these studies were inconclusive and inconsistent. We evaluated the potential relationship between IBD and PD risk by a meta-analysis.Methods: Search the electronic databases PubMed, Embase and Cochrane databases from inception to November 30, 2022, to identify relevant studies that assess the risk of PD in patients with IBD. The cohort, cross-sectional, mendelian randomization and case-control studies that reported risk estimates of PD and IBD were included in our analysis. The random-effect model and fixed-effects model were used to calculate the summary relative risks (RRs) with 95% confidence intervals (CIs).Results: In total, 14 studies (nine cohort studies, two cross-sectional studies, two mendelian randomization studies and one case-control study) involving more than 13.4 million individuals were analyzed in our analysis. Our results suggested that the risk of PD in IBD patients is moderately increased, with the pooled RR was 1.17 (95% CI: 1.03–1.33, P = 0.019). Omit of any single study from this analysis had little effect on the combined risk estimate. No evidence of publication bias was found. In the subgroup analysis, the combined RR was 1.04 (95% CI: 0.96, 1.12, P = 0.311) for Crohn’s disease (CD), and 1.18 (95% CI: 1.06, 1.31, P = 0.002) for ulcerative colitis (UC). In addition, a significant association was identified in patients with IBD aged ≥ 60 years (RR = 1.22; 95% CI: 1.06–1.41, P = 0.007), but not in age < 60 years (RR = 1.19; 95% CI: 0.58–2.41, P = 0.639). Meanwhile, the meta-analysis results suggested a protective role for IBD medication use against PD development, with the RR was 0.88 (95% CI: 0.74, 1.04, P = 0.126).Conclusion: Our results indicated that patients with IBD had a moderately higher risk of PD compared to non-IBD individuals. Patients with IBD should be aware of the potential risks for PD, especially who were ≥ 60 years old.

1 June 2016 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
GHGuangliang Han
Guangliang Han
HLHongxin Li
Hongxin Li
XPXiao-Xiao Peng
Xiao-Xiao Peng
QZQiang Zong
Qiang Zong
KZKai Zhang
Kai Zhang
YLYi-Zhe Liu
Yi-Zhe Liu
Cigarette smoking and risk of adult glioma: a meta-analysis of 24 observational studies involving more than 2.3 million individuals Hong-xing Li,1,* Xiao-xiao Peng,1,2,* Qiang Zong,1 Kai Zhang,1 Ming-xin Wang,1 Yi-zhe Liu,1 Guang-liang Han1 1Department of Neurosurgery, Shengli Oilfield Central Hospital, 2Department of Intensive Care Unit, Dongying, Shandong, People’s Republic of China *These authors contributed equally to this work Background: Cigarette smoking has been shown to be a risk factor for adult glioma by some but not all studies. We conducted a meta-analysis to systematically assess the potential association. Methods: PubMed and EMBASE were searched from the date of their inception to October 1, 2015, to identify relevant articles. Reference lists from these articles were reviewed to identify additional studies. Both cohort and case–control studies were included. Fixed-effects models were used to calculate the overall relative risk (RR) with corresponding 95% confidence intervals (CIs). Results: The final analysis included 24 studies (seven cohort and 17 case–control studies), involving more than 2.3 million individuals. The combined RR was 1.04 (95% CI: 1.00, 1.09; P=0.073) for ever-smokers, 0.97 (95% CI: 0.88, 1.07; P=0.574) for current-smokers, and 1.07 (95% CI: 0.98, 1.16; P=0.130) for past smokers, with little evidence of heterogeneity. Omission of any single study from the analysis had little effect on the result. No evidence of publication bias was found. A small but statistically significant increase was found in past smokers in females (RR: 1.13, 95% CI: 1.00, 1.28; P=0.046) but not in males. Conclusion: In general, there was no association between cigarette smoking and adult glioma. The small but statistically significant association in females requires further investigation. Keywords: cigarette smoking, glioma, meta-analysis, risk

1 February 2017 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
SYSheng-Ye Yang
Sheng-Ye Yang
HLHongxin Li
Hongxin Li
XYXin-Hao Yi
Xin-Hao Yi
GHGuang-Liang Han
Guang-Liang Han
QZQiang Zong
Qiang Zong
XPXiao-Xiao Peng
Xiao-Xiao Peng

5 November 2020 in Brain Imaging and Behavior
Verified
Journal Article
Closed access
PDF file
MZMin Zeng
Min Zeng
MYMin Yu
Min Yu
GQGuiqiang Qi
Guiqiang Qi
SZShaojin Zhang
Shaojin Zhang
JMJijian Ma
Jijian Ma
JXJinping Xu
Jinping Xu

1 October 2020 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
HLHongxin Li
Hongxin Li
LZLin Zuo
Lin Zuo
XPXiao-Xiao Peng
Xiao-Xiao Peng
QZQiang Zong
Qiang Zong
KZKai Zhang
Kai Zhang
GHGuangliang Han
Guangliang Han

23 October 2014 in Oncology Research
Verified
Journal Article
Open access
LHLi Hu
Li Hu
LLLi-Li Li
Li-Li Li
ZLZhi-Guo Lin
Zhi-Guo Lin
ZJZhi-Chao Jiang
Zhi-Chao Jiang
HLHongxin Li
Hongxin Li
KYKong-Bin Yang
Kong-Bin Yang
The potassium (K+) channel plays an important role in the cell cycle and proliferation of tumor cells, while its role in brain glioma cells and the signaling pathways remains unclear. We used tetraethylammonium (TEA), a nonselective antagonist of big conductance K+ channels, to block K+ channels in glioma cells, and antioxidant N-acetyl-l-cysteine (NAC) to inhibit production of intracellular reactive oxygen species (ROS). TEA showed an antiproliferation effect on C6 and U87 glioma cells in a time-dependent manner, which was accompanied by an increased intracellular ROS level. Antioxidant NAC pretreatment reversed TEA-mediated antiproliferation and restored ROS level. TEA treatment also caused significant increases in mRNA and protein levels of tumor-suppressor proteins p53 and p21, and the upregulation was attenuated by pretreatment of NAC. Our results suggest that K+ channel activity significantly contributes to brain glioma cell proliferation via increasing ROS, and it might be an upstream factor triggering the activation of the p53/p21Cip1-dependent signaling pathway, consequently leading to glioma cell cycle arrest.